New Delhi: India reported on Tuesday 28,204 COVID-19 infections over the last 24 hours, the lowest since March 16, according to government data.
India’s overall case load touched 32 million, the health ministry data showed. Overall deaths in the country increased by 373 overnight, pushing the tally to 428,682.
The national COVID-19 recovery rate has increased to 97.45 per cent, which is the highest ever recovery rate achieved, the ministry said.
The death toll has climbed to 4,28,682 with 373 fresh fatalities, the data updated at 8am showed.
The active cases comprise 1.21 per cent of the total infections, the lowest since March 2020, the ministry said.
A decrease of 13,680 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.
As many as 15,11,313 tests were conducted on Monday taking the total cumulative tests conducted so far for detection of COVID-19 in the country to 48,32,78,545.
The daily positivity rate has declined to 1.87 per cent. It has been less than three per cent for the last 15 days, the ministry said, adding the weekly positivity rate was recorded at 2.36 per cent.
The number of people who have recuperated from the disease surged to 3,11,80,968, while the case fatality rate stands at 1.34 per cent, the data stated.
Cumulatively, 51.45 crore COVID-19 vaccine doses have been administered under the nationwide vaccination drive till Tuesday morning.
The ministry stressed that more than 70 per cent of the deaths occurred due to comorbidities.
“Our figures are being reconciled with the Indian Council of Medical Research,” the ministry said on its website, adding that state-wise distribution of figures is subject to further verification and reconciliation.
Meanwhile, India’s vaccination coverage has crossed 510 million cumulatively. A total of 54,91,647 doses of vaccines were administered in the last 24 hours, pushing the total vaccination so far at 51,45,00,268, said the bulletin.
More than 520.56 million (52,56,35,710) vaccine doses have been provided to the states/UTs so far, through all sources and a further 48,43,100 doses are in the pipeline, pointed out the health ministry data.
Also, Union minister Mansukh Mandaviya on Tuesday said the government has given approval to Bharat Biotech’s Ankleshwar-based manufacturing plant to produce COVID-19 vaccine Covaxin.
“Govt of India approves vaccine manufacturing facility for production of @BharatBiotech’s #Covaxin in Ankleshwar, Gujarat,” Mandaviya tweeted.
The approval would help increase availability of COVID-19 vaccines in the country, he added.
“Following PM @NarendraModi ji’s vision of #SabkoVaccineMuftVaccine, this will increase vaccine availability & accelerate the world’s largest vaccine drive,” the minister who heads both Chemicals and Fertilisers and Health ministries noted.
In May this year, Bharat Biotech had announced that it plans to produce an additional 200 million doses of Covaxin at its subsidiary’s Ankleshwar-based facility.
The Hyderabad-based firm had noted that it would utilise the manufacturing plant of its wholly-owned unit - Chiron Behring, to add another 200 million doses of Covaxin.
